List of Liletta drug patents

Liletta is owned by Medicines360.

Liletta contains Levonorgestrel.

Liletta has a total of 2 drug patents out of which 0 drug patents have expired.

Liletta was authorised for market use on 26 February, 2015.

Liletta is available in intrauterine device;intrauterine dosage forms.

Liletta can be used as a method for prevention of pregnancy.

The generics of Liletta are possible to be released after 22 March, 2034.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11090186 MEDICINES360 Methods for using intrauterine systems and IUD insertion devices
Oct, 2033

(10 years from now)

US10028858 MEDICINES360 Intrauterine systems, IUD insertion devices, and related methods and kits therefor
Mar, 2034

(11 years from now)

Drugs and Companies using LEVONORGESTREL ingredient

Market Authorisation Date: 26 February, 2015

Treatment: A method for prevention of pregnancy


More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in